成功管理与阻燃性托克索普拉斯菌相关的斑点新血管化与内腔法里西马布
Şefik Can İpek1, Seher Köksaldı2, Mustafa Kayabaşı3
1Department of Ophthalmology, Private Practice, Denizli, 20100, Turkey.
Acta parasitologica
|February 18, 2026
概括
内法利西马布改善视力和减少液体在一个患者的斑点新血管化从抗毒素的抗其他治疗方法. 法里西马布 法里西马布 法里西马布 法里西马布 法里西马布
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 传染性疾病 传染性疾病
背景情况:
- 黄斑新血管化 (MNV) 可能发生在眼睛毒中.
- 耐治疗的MNV构成了重大的临床挑战.
- 抗血管内皮生长因子 (抗VEGF) 疗法是标准的,但可能并不总是有效的.
研究的目的:
- 为了评估内法利西马布的治疗疗效.
- 评估法里西马布对耐火性MNV的作用,这是毒素质胆红素炎的次要原因.
主要方法:
- 一个29岁的妇女的病例报告,患有眼部毒素菌和二次MNV.
- 之前的治疗包括内贝瓦西祖马布和阿弗利塞普特,但成功程度有限.
- 一次静脉内注射法里西马布 (faricimab) 被使用.
主要成果:
- 患者呈现视力敏度下降和成像证实了带有出血和液体的亚叶MNV.
- 在注射法里西马布后,视力敏度从数指提高到0.2.
- 光学连贯性断层扫描显示,三个月后,子液的完全分离,斑点厚度减少.
结论:
- 内法利西马布在耐火性MNV中显著的解剖学和功能性改善,这是毒性质胆红素炎的次要原因.
- 法里西马布对VEGF-A和angiopoetin-2的双重抑制可能对炎症性神经血管病变有益.
- 法里西马布代表了对MNV具有挑战性的病例的潜在治疗选择.
相关概念视频
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K


